Results for tag: "Bromodomain Containing Protein 2"

Bromodomain Containing Protein 2 (BRD2) is a protein that plays a role in the regulation of gene expression. It is a member of the bromodomain and extra-terminal (BET) family of proteins, which are involved in the regulation of chromatin structure and gene expression. BRD2 has been studied in the context of oncology drugs, as it has been found to be involved in the regulation of cancer-related genes. BRD2 has been studied in the context of cancer drug development, as it has been found to be involved in the regulation of cancer-related genes. In particular, BRD2 has been studied in the context of epigenetic therapies, which are drugs that target epigenetic regulators such as BRD2 to modulate gene expression. Several companies are developing drugs targeting BRD2, including AbbVie, AstraZeneca, and Merck. Additionally, several biotech companies are developing drugs targeting BRD2, including Epizyme, Constellation Pharmaceuticals, and Arvinas. Show Less Read more